STERIS plc $STE Stock Holdings Lifted by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC grew its stake in shares of STERIS plc (NYSE:STE) by 17.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 14,735 shares of the medical equipment provider’s stock after acquiring an additional 2,150 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in STERIS were worth $3,647,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Mediolanum International Funds Ltd lifted its holdings in shares of STERIS by 9.0% during the 2nd quarter. Mediolanum International Funds Ltd now owns 62,327 shares of the medical equipment provider’s stock valued at $14,883,000 after buying an additional 5,156 shares during the last quarter. Entropy Technologies LP increased its holdings in STERIS by 282.2% in the second quarter. Entropy Technologies LP now owns 9,099 shares of the medical equipment provider’s stock worth $2,186,000 after buying an additional 6,718 shares during the last quarter. Vanguard Group Inc. raised its position in STERIS by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,163,128 shares of the medical equipment provider’s stock valued at $2,921,827,000 after acquiring an additional 205,276 shares in the last quarter. Asset Management One Co. Ltd. lifted its stake in STERIS by 5.4% in the third quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider’s stock valued at $24,366,000 after acquiring an additional 5,072 shares during the last quarter. Finally, Cerity Partners LLC lifted its stake in STERIS by 28.8% in the third quarter. Cerity Partners LLC now owns 96,853 shares of the medical equipment provider’s stock valued at $23,966,000 after acquiring an additional 21,656 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

STERIS Stock Down 0.9%

Shares of STE stock opened at $260.70 on Thursday. The stock’s 50 day simple moving average is $259.21 and its 200 day simple moving average is $248.25. STERIS plc has a twelve month low of $204.90 and a twelve month high of $269.44. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.63 and a current ratio of 2.37. The company has a market capitalization of $25.59 billion, a price-to-earnings ratio of 37.46 and a beta of 1.03.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The firm had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the prior year, the business earned $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, February 17th. STERIS’s dividend payout ratio (DPR) is 36.21%.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $273.50.

Insider Buying and Selling

In other STERIS news, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the transaction, the vice president owned 33,669 shares of the company’s stock, valued at $8,926,998.66. The trade was a 30.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Renato Tamaro sold 5,036 shares of the company’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the sale, the vice president owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This trade represents a 46.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 25,044 shares of company stock worth $6,586,218 in the last quarter. 1.07% of the stock is currently owned by company insiders.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.